Fertility Market in the US 2016-2020 - Key Vendors are Cellcura, CooperSurgical, Intramed, Ferring Pharmaceuticals & Merck

The fertility services market in the US is expected to grow at a CAGR of 4.07% during the period 2016-2020.

DUBLIN, 12/02/2016 (informazione.it - comunicati stampa - editoria e media)

The fertility services market in the US is expected to grow at a CAGR of 4.07% during the period 2016-2020.

Vendors undergo M&A to expand their geographical presence, enhance their product portfolio, and attain profit margins. M&A allows vendors to gain proprietary technologies and innovative products of the acquired company. Small vendors undergo M&A to broaden their network and expand people's access to their new products.

According to the report, the fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period.

Further, the report states that high cost of fertility treatment hinders the market growth.

Key questions answered in this report:

Key vendors:

Other prominent vendors:

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Regulatory scenario in the US

PART 06: Market landscape

PART 07: Infertility: An overview